Clinical utility of anticardiolipin antibody assays: High inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach

Pathology

Volumn 31, Issue 2, 1999, Pages 142-147

  Favaloro, Emmanuel J ^a   Silvestrini, Roger ^b   Mohammed, Ali ^b  

^a Sydney West Area Health Service NSW Health   (Australia)

^b NONE

Author keywords

Anticardiolipin antibody; Antiphospholipid antibody; Antiphospholipid syndrome; Assays; Laboratory assessment; Quality assurance

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD ANALYSIS; IMMUNOASSAY; LABORATORY TEST; QUALITY CONTROL; STANDARDIZATION;

EID: 0033029444     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/003130299105331     Document Type: Article

References (14)

1. 1. Harris EN. Antiphospholipid antibodies, Brit J Hematol 1990; 70: 1-9.
2. 2. Harris EN, Gharavi AEM, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GRV. Anti-cardiolipin antibodies: detection by radio-immunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211-4.
3. 3. Triplett DA, Brandt JT, Musgrave KA, Orr CA. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 1988; 259: 550-4.
4. 4. Ginsberg JS, Wells PS, Brill-Edwards P, Donavan D, Moffatt K, Johnston M, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 10: 3685-91.
5. 5. Pengo V, Thiagarajan P, Shapiro SS, Heine MJ. Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood 1987; 70: 69-76.
6. 6. Harris EN, Chan JKH, Asherson RA, Aber VA, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, thrombocytopenia: Predictive value of IgG anticardiolipin anybodies. Arch Intern Med 1986; 146: 2153-6.
7. 7. Ginsberg KS, Liang MII, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992; 117: 997-1002.
8. 8. Court EL. Lupus anticoagulants: Pathogenesis and laboratory diagnosis. Brit J Biomed Sci 1997; 54: 287-98.
9. 9. Galli M, Finazzi G, Barbui T. Antiphospholipid antibodies: Predictive value of laboratory tests. Thromb Hemost 1997; 77: 75-8.
10. 10. Vermylen J, Hoylacrts MF, Arnout J. Antibody-mediated thrombosis. Thromb Hemost 1997; 77: 420-26.
11. 11. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-4.
12. 12. McNeill HP, Krillis SA. Antiphospholipid antibodies. Aust NZJ Med 21: 463-75.
13. 13. Triplett DA. Protean clinical presentation of antiphospholipid antibodies (APA). Thromb Hemost 1995; 74: 329-37.
14. 14. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the ACA test: report of an international workshop held 4 April 1986. Clin Exp Immunol 68: 215-22.